Press Releases

LOS ANGELES, Nov. 18, 2019 /PRNewswire/ -- SONIFI Health, a leader in interactive patient engagement and education technology, today announced a partnership with Stratus Video, an industry leader in innovative language services. The integration of the two companies' platforms will help improve communication and education between healthcare providers and their patien

BUFFALO, N.Y. and SHANGHAI, Nov. 18, 2019 /PRNewswire/ -- MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (Fosun Pharma Industrial) today announced the companies have entered into a China-exclusive licensing agreement for SurVaxM, a novel anti-cancer immunotherapy in the treat

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- KRY/LIVI takes a new and important step to revolutionise healthcare by introducing seamless digi-physical services in the south of Sweden. A new physical centre opens in Malmö to complement the KRY app. This new approach will fill the gap between digital and physical care and make the care flo

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen, Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In

LONDON, Nov. 18, 2019 /PRNewswire/ -- Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) announces that its venture capital arm,

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Scandinavian ChemoTech and its CEO Mohan Frick has been selected to present its Tumour Specific Electroporation at the Emerging Medtech Summit in California, USA. An event bringing together the top strategists, investors, and innovators within the Medtech indust

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) reports today that the ninth and final patient was recruited to the phase Ia study of MIV-818 in patients with advanced liver cancer. Based on data from phase Ia, the initial dose of MIV-818 for the phase Ib study has been determined at 200 mg / week. The dosage is given as 40 mg / d

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at

RAMAT GAN, Israel, Nov. 18, 2019 /PRNewswire/ -- The international iReceptor Plus Project will hold a joint meeting with the SCAIR community in Haifa, Israel as part of its continued efforts to expand the iReceptor Plus stakeho

TAIPEI, Nov. 18, 2019 /PRNewswire/ -- About 70% of human body is composed of water. However, according to the Quench Survey, nearly 80% of working Americans say they don't drink enough water. Keeping hydrated is crucial for a person's health and well-being, but there is a substantial amount of people who do not consume enough water da